TC-2559: a novel orally active ligand selective at neuronal acetylcholine receptors. (Q52144183)

23 April 2018

title

TC-2559: a novel orally active ligand selective at neuronal acetylcholine receptors. (English)

1 reference

23 April 2018

author name string

Bencherif M

1

1 reference

23 April 2018

Bane AJ

2

1 reference

23 April 2018

Miller CH

3

1 reference

23 April 2018

Dull GM

4

1 reference

23 April 2018

Gatto GJ

5

1 reference

23 April 2018

language of work or name

English

0 references

publication date

1 December 2000

1 reference

23 April 2018

European Journal of Pharmacology

published in

1 reference

23 April 2018

volume

409

1 reference

23 April 2018

page(s)

45-55

1 reference

23 April 2018

issue

1

1 reference

23 April 2018

Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

Nicotine enhances the learning and memory of aged rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

(-)-nicotine protects against systemic kainic acid-induced excitotoxic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

(S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

Immunohistochemical localization of the nicotinic acetylcholine receptor subunit alpha6 to dopaminergic neurons in the substantia nigra and ventral tegmental area.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

Human neuronal nicotinic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: an analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via alpha7-neuronal receptors and neuronal CNS receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

Chronic nicotine and withdrawal effects on radial-arm maze performance in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

GTS-21, a nicotinic agonist, protects against neocortical neuronal cell loss induced by the nucleus basalis magnocellularis lesion in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

The activation and inhibition of human nicotinic acetylcholine receptor by RJR-2403 indicate a selectivity for the alpha4beta2 receptor subtype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

Nicotine inhibits amyloid formation by the beta-peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

Effects of chronic nicotine and pilocarpine administration on neocortical neuronal density and [3H]GABA uptake in nucleus basalis lesioned rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

A microdialysis study of the effects of the nicotinic agonist RJR-2403 on cortical release of acetylcholine and biogenic amines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

Nicotine rescues PC12 cells from death induced by nerve growth factor deprivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900807-4

10.1016/S0014-2999(00)00807-4

7 January 2021

Identifiers

DOI

1 reference

23 April 2018

PubMed ID

11099699

1 reference

23 April 2018